Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-11-02

Clinical Trial Update: Clinical Efficacy of the Drug Ster® Compared With Predfort® in Control of Postoperative Inflammation in Cataract Surgery [Phase 3]

View source ↗

Summary

Phase 3 trial assessing the efficacy of Ster® versus Predfort® in controlling postoperative inflammation after cataract surgery.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Predfort®
  • Ster®

Snippet

Sponsor: Azidus Brasil | Conditions: Inflammation, Cataract Surgery | Phase 3 | Status: COMPLETED